ResMed (RMD) Tops Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.99 -1.5%
Revenue Growth %: +6.9%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.9%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $2.55, $0.03 better than the analyst estimate of $2.52. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Starts L1 Group Ltd (L1G:AU) at Buy
- Trump says U.S. and Denmark reached permanent security deal over Greenland
- HSBC Double Downgrades Compania Cervecerias Unidas (CCU) to Reduce
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
